Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Qiagen ( (QGEN) ) just unveiled an announcement.
Qiagen N.V., a prominent player in the life sciences industry, has been notified by the Netherlands Authority for the Financial Markets (AFM) regarding a significant voting rights announcement. BlackRock, Inc. has disclosed its holdings in Qiagen, with a total capital interest of 9.74% and voting rights of 10.86%, primarily held indirectly through various subsidiaries. This announcement highlights BlackRock’s substantial influence in Qiagen, potentially impacting the company’s strategic decisions and market positioning.
The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Average Trading Volume: 1,333,605
Technical Sentiment Signal: Sell
Current Market Cap: $9.28B
For an in-depth examination of QGEN stock, go to TipRanks’ Stock Analysis page.